ESMO 2023: STELLAR-304: A Randomized Phase 3 Study of Zanzal

ESMO 2023: STELLAR-304: A Randomized Phase 3 Study of Zanzalintinib (XL092) and Nivolumab in Non-Clear Cell Renal Cell Carcinoma

ESMO 2023: STELLAR-304: A Randomized Phase 3 Study of Zanzalintinib (XL092) and Nivolumab in Non-Clear Cell Renal Cell Carcinoma

urotoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from urotoday.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Georgia , United States , Madrid , Spain , America , Monty Pal , Zachary Klaassen , Sumantak Pal , Georgia Cancer Center , City Of Hope Cancer Center , Twitter , European Society Of Medical Oncology , South America , Hope Cancer Center , Urologic Oncologist , Associate Professor , Medical Oncology , Annual Meeting , Novel Receptor Tyrosine Kinase Inhibitor ,